Effects of Gong's Mobilization With and Without Scapular High Lift on Shoulder Range of Motion and Functional Recovery in Adhesive Capsulitis. (Gongs Mob)

August 10, 2026 updated by: Danyal Ahmad, University of Management and Technology Sialkot Pakistan

Effects of Gong's Mobilization With and Without Scapular High Lift on Shoulder Range of Motion and Functional Recovery in Adhesive Capsulitis; a Randomized Clinical Trial

This study aims to compare the effectiveness of Gongs Mobilization with and without scapular High-lift in the management of Adhesive Capsulitis, focusing on specific outcomes like pain, functional outcomes, and work productivity.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study will be a randomized controlled trial with a sample size of 42 participants, as calculated by the G power tool, with 5 % attrition rate, diagnosed with Adhesive Capsulitis. Subjects will be selected through non-probability convenient sampling based on inclusion and exclusion criteria, and randomly assigned into two groups, with 21 participants in each group. Group A will receive Gong mobilization with scapular high-lift, while Group B will receive Gong mobilization without scapular high-lift, both in conjunction with conventional therapy. Demographic Data will also be collected. Baseline and post-intervention data will be collected using SPADI, NPRS, and a goniometer. Data will be analyzed by using IBM SPSS 26.0. At the same time, the Shapiro-Wilk test will be applied to check normality.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
42

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab Province
      • Sialkot, Punjab Province, Pakistan, 51040
        • Bethania Hospital Sialkot
      • Sialkot, Punjab Province, Pakistan, 51310
        • Raheem Surgical Hospital Sambrial
      • Sialkot, Punjab Province, Pakistan, 51310
        • University of Management and technology Sialkot Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants, including both males and females.
  • aged 40 to 60 years.
  • Diagnosed with unilateral Adhesive capsulitis at the 2nd or 3rd stage of the disease

Exclusion Criteria:

  • History of any trauma, tumor, fracture, surgery, or infection in a shoulder joint.
  • Patient with pregnancy and a history of abnormal neurological status (radiculopathy, stroke with hemiplegia, brachial plexus injury).
  • Restricted shoulder due to burns or postoperative scars.
  • Moderate or High levels of diabetes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS)
GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS) containing 21 participants who will be given Gong's mobilization with scapular high lifts for 30 minutes along with the conventional physiotherapy.
Other: Experimental: GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS)
In this technique, the therapist applies a sustained lateral glide to the humeral head while the patient actively performs shoulder elevation or abduction. Scapular high lifting is encouraged during the movement to assist shoulder elevation. The technique is performed within a pain-free range to reduce pain and improve shoulder mobility and functional movement.
Experimental: GROUP B (GONG'S MOBILIZATION WITHOUT SCAPULAR HIGHLIFTS)
GROUP B (GONG'S MOBILIZATION WITHOUT SCAPULAR HIGHLIFTS) containing 21 participants who were given Gong's mobilization without scapular high lifts for 30 minutes along with the conventional physiotherapy
Other: Experimental: GROUP B (GONG'S MOBILIZATION WITHOUT SCAPULAR HIGHLIFTS)
Patients received Gong's mobilization without allowing scapular high lifting. The therapist applied a lateral glide to the humeral head while the patient performed pain-free shoulder elevation or abduction. Scapular movement was controlled to avoid compensation, aiming to reduce pain and improve shoulder mobility and function.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
NUMERICAL PAIN RATING SCALE (NPRS)
Time Frame: 4 Weeks
It is a fundamental tool used to evaluate pain intensity and pain tolerance. Subjects can rate their pain from 0 (no pain at all) to 10 (pain as bad as it could be) to check whether the pain is acute or chronic. 42. The test-retest reliability coefficient, the intra-class correlation coefficient (ICC) for NPRS, is 0.74, and the minimal clinically important difference (MCID) is 1.1 points
4 Weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
SHOULDER PAIN AND DISABILITY INDEX (SPADI)
Time Frame: 4 Weeks
SPADI is used to assess shoulder discomfort and impairment in patients with shoulder disorders. It consists of 13 items divided into two domains; a sub-scale that measures pain contains 5 items, and the other sub-scale consists of 8 items to assess disability. Every sub-scale has a scoring method that calculates the average (mean) at the end to make a score out of 100. A high score indicates greater impairment or disability, and vice versa. The reliability coefficient, the intra-class correlation, is ≥ 0.89, and its minimal clinically important difference (MCID) is 8 points
4 Weeks
UNIVERSAL GONIOMETERY:
Time Frame: 4 Weeks
The primary movements of the shoulder include flexion and extension, abduction and adduction, horizontal abduction and adduction, as well as lateral and medial rotation. While these movements are assessed at the glenohumeral joint, they rely on coordinated mobility at the sternoclavicular, acromioclavicular, and scapulothoracic joints41. For shoulder AROM, the reliability coefficient, intra-class correlation (ICC), is 0.53-0.6544. The ICC for PROM ranges from 0.87 to 0.99
4 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Management and Technology Sialkot Pakistan

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Hamza Zahid, MS OMPT, University of Management and Technology Sialkot Pakistan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 1, 2026

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 30, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 30, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 22, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 22, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 7, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 12, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 10, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • kuhs/dpt/umt-skt-027

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

IPD may not be shared due to concerns regarding patient confidentiality, data ownership, ethical approvals, and consent limitations, as well as institutional or legal restrictions. Additionally, data may be withheld to protect ongoing analyses or unpublished results, or because the data contain sensitive information that cannot be fully anonymized.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings